期刊文献+

以淋巴增殖性疾病为表现的套细胞淋巴瘤的临床与诊断分析 被引量:8

Clinical analysis and diagnosis of mantle cell lymphoma presented as lympho-proliferative disease
暂未订购
导出
摘要 目的:研究以慢性B淋巴细胞增殖性疾病(B-LPD)为表现的套细胞淋巴瘤(MCL)的临床特点与诊断。方法:对过去7年间以LPD为主要表现并可诊断为MCL的15例患者的临床特点和诊断进行回顾性分析。结果:①15例MCL中,依靠病理及CyclinD1诊断6例,依靠典型的免疫表型特征诊断9例;②部分以LPD表现的MCL患者临床表现、瘤细胞形态与慢性淋巴细胞白血病(CLL)难以区别,而免疫表型分析不符合CLL特点;③淋巴结或脾脏病理检查结合免疫组织化学是诊断MCL的主要依据,典型的免疫表型对MCL的诊断价值值得探讨。结论:部分MCL患者以广泛侵犯骨髓的LPD发病,对不典型LPD应进行病理检查明确诊断,而不能按CLL处理,以免贻误治疗。 Objective:To study the clinical features and diagnosis of mantle cell lymphoma presented as lympho-proliferative disease. Method:The clinical features and diagnosis of 15 cases of MCL presented as lympho-proliferative disease were retrospectively analyzed. Result:(1) Six of the 15 cases of MCL were diagnosed by histopathology and immunohistochemistry, and the other nine cases were diagnosed by immunophenotype in addition to the features of B-LPD;(2)The MCL patients presented as B lympho-proliferative disease shared the similar clinical features and morphological characteristics with CLL, while their immunophenotypes were valuable for differential diagnosis;(3)Histopathological examination of lymph node or spleen was the main method for confirmation diagnosis and the value of typical immunophenotype in the diagnosis deserved further discussion. Conclusion: Some MCL patients presented like B-LPD and the confirmed diagnosis was required rather than simply treated as CLL.
出处 《临床血液学杂志》 CAS 2009年第3期225-228,共4页 Journal of Clinical Hematology
基金 天津市自然科学基金资助项目(No:06YFJMSC08500)
关键词 套细胞淋巴瘤 淋巴细胞增殖性疾病 诊断 mantle cell lymphoma lympho-proliferative disease diagnosis
  • 相关文献

参考文献8

  • 1DECAUDIN D. Mantle cell lymphoma: a biological and therapeutic paradigm[J]. Leuk Lymphoma,2002, 43:773--781.
  • 2VELDERS G A,KLUIN-NELEMANS J C, DE BOER C J, et al. Mantle-cell lymphoma., a population-based clinical study[J]. J Clin Oncol, 1996,14 : 1269 - 1274.
  • 3唐泽海,张敏,邹萍,刘新月,游泳.套细胞淋巴瘤41例临床分析[J].华中科技大学学报(医学版),2007,36(4):528-530. 被引量:7
  • 4FERRER A, SALAVERRIA I, BOSCH F, et al. Leukemic involvement is a common feature in mantle cell lymphoma[J]. Cancer,2007,109 :2473--2480.
  • 5COHEN P L,KURTIN P J,DONOVAN K A,et al. Bone marrow and peripheral blood involvement in mantle cell lymphoma[J].Br J Haematol, 1998,101: 302--310.
  • 6MATUTES E, OWUSU-ANKOMAH K, MORILLA R,et al. The immunological profile of B-cell disorders and proposal of a scoringsystem for the diagnosis of CLL[J].Leukemia, 1994,8 : 1640-- 1645.
  • 7MATUTES E,PARRY-JONES N,BRITO-BABAPU LLE V, et al. The leukemic presentation of mantle cell lymphoma:disease features and prognostic factors in 58 patients[J]. Leuk Lymphoma, 2004,45 : 2007 -- 2015.
  • 8VIZCARRA E, MARTINEZ-CLIMENT J A, BENET I,et al. Identification of two subgroups of mantle cell leukemia with distinct elinical and biological features [J]. Hematol J, 2001,2 : 234-- 241.

二级参考文献2

共引文献6

同被引文献60

  • 1孙峰,保方,陈秀芳,尹红.骨髓增生异常综合征106例骨髓病理观察[J].南通大学学报(医学版),2005,25(2):118-119. 被引量:3
  • 2吴雨洁,李建勇,朱光荣,宋君红,肖冰.ZAP-70在24例B细胞慢性淋巴细胞白血病中的表达研究[J].中国实验血液学杂志,2006,14(2):237-240. 被引量:16
  • 3Jaeffee ES,Harris N L,Stein H,et al.World health organization classification of tumors.Pathology and genetics of tumors of hematopoietic and lymphoid tissues.Lyon:IARC Press,2001.215-289.
  • 4Kasamon YL.Blood or marrow transplantation for mantle cell lymphoma.Curr Opin Oncol,2007,19:128-135.
  • 5Matutes E,Owusu-ankomah K,Morillar,et al.The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL[J].Leukemia,1994,8:1640-1645.
  • 6LISA G S,NIELS T.An international system for human cytogenetic nomenclature[J].Basel:ISCN,2005:39-46.
  • 7XU W,LI J Y,PAN J L,et al.Interphase.Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia[J].Int J Haematol,2007,85:430-436.
  • 8SWERDLOW S H,WILLIAMS M E.From centrocytic to mantle cell lymphoma:a clinicopathologic and molecular review of 3 decades[J].Hum Pathol,2002,33:7-20.
  • 9MATUTES E,PARRY-JONES N,BRITO-BABAPU-LLE V,et al.The leukemic presentation of mantle-cell lymphoma:disease features and prognostic factors in 58 patients[J].Leuk Lymphoma,2004,45:2007-2015.
  • 10BARNA G,REINIGER L,TATRAI P,et al.The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL[J].Hematol Oncol,2008,26:167-170.

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部